Article
Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters.
British journal of clinical pharmacology - 1 Aug 2016
Milosheska Daniela, Lorber Bogdan, Vovk Tomaž, Kastelic Matej, Dolžan Vita, Grabnar Iztok
Abstract excerpt
AIMS: This study aimed to develop a population pharmacokinetic model for quantitative evaluation of the influence of genetic variants in metabolic enzymes and transporters on lamotrigine pharmacokinetics while taking into account the influence of various clinical, biochemical and demographic factors. METHODS: We included 100 patients with epilepsy on stable dosing with lamotrigine as mono or adjunctive therapy....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
